Literature DB >> 23430494

Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer.

Stuart Lavery1, Dima Abdo, Mara Kotrotsou, Geoff Trew, Michalis Konstantinidis, Dagan Wells.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive inherited metabolic disorder caused by a complete or near-complete deficiency of the liver enzyme phenylalanine hydroxylase (PAH), which converts the amino acid phenylalanine to tyrosine, leading to the increase of blood and tissue concentration of phenylalanine to toxic levels. PKU is not life threatening but is treated through lifelong dietary management. If untreated, it can lead to severe learning disability, brain function abnormalities, behavioural and neurological problems. The non-life threatening nature of PKU has until now caused some debate on whether to licence its detection by preimplantation genetic diagnosis (PGD). We report the first successful live birth in the UK following single cell embryo biopsy and PGD for the detection of two different mutations in the (PAH) gene. This case highlights both an important scientific development as well as the ethical challenge in offering couples who carry PKU this new reproductive option when starting their family.

Entities:  

Year:  2012        PMID: 23430494      PMCID: PMC3575040          DOI: 10.1007/8904_2012_140

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  24 in total

1.  Biopsy of human preimplantation embryos and sexing by DNA amplification.

Authors:  A H Handyside; J K Pattinson; R J Penketh; J D Delhanty; R M Winston; E G Tuddenham
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 2.  Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies.

Authors:  Babette W Prick; Wim C J Hop; Johannes J Duvekot
Journal:  Am J Clin Nutr       Date:  2011-12-28       Impact factor: 7.045

3.  Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer.

Authors:  D K Gardner; M Lane; J Stevens; T Schlenker; W B Schoolcraft
Journal:  Fertil Steril       Date:  2000-06       Impact factor: 7.329

4.  Prepregnancy testing for single-gene disorders by polar body analysis.

Authors:  Y Verlinsky; S Rechitsky; O Verlinsky; V Ivachnenko; A Lifchez; B Kaplan; J Moise; J Valle; A Borkowski; J Nefedova; E Goltsman; C Strom; A Kuliev
Journal:  Genet Test       Date:  1999

5.  Stability of blood phenylalanine levels and IQ in children with phenylketonuria.

Authors:  Vera Anastasoaie; Laura Kurzius; Peter Forbes; Susan Waisbren
Journal:  Mol Genet Metab       Date:  2008-08-13       Impact factor: 4.797

6.  Review of neonatal screening programme for phenylketonuria.

Authors:  I Smith; B Cook; M Beasley
Journal:  BMJ       Date:  1991-08-10

7.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

8.  Follow up of fetal outcome in cases of maternal phenylketonuria in Northern Ireland.

Authors:  A C Magee; K Ryan; A Moore; E R Trimble
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

9.  The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

Authors:  P Hardelid; M Cortina-Borja; A Munro; H Jones; M Cleary; M P Champion; Y Foo; C R Scriver; C Dezateux
Journal:  Ann Hum Genet       Date:  2008-01       Impact factor: 1.670

10.  Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).

Authors:  Eva Simon; Martin Schwarz; Judith Roos; Nico Dragano; Max Geraedts; Johannes Siegrist; Gudrun Kamp; Udo Wendel
Journal:  Health Qual Life Outcomes       Date:  2008-03-26       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.